Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J6TN
|
||||
| Former ID |
DIB004370
|
||||
| Drug Name |
2085-P
|
||||
| Synonyms |
VD-2085
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Otitis media [ICD10:H65-H67] | Discontinued in Phase 3 | [1] | ||
| Company |
LEO Pharma A/S
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C30H39BrN4O9S2
|
||||
| Canonical SMILES |
N12[C@@H]([C@@H](C1=O)NC(=O)[C@@H](c1ccccc1)N)SC([C@@H]<br />2C(=O)OCOC(=O)C(C)(C)C)(C)C.N12[C@@H]([C@@H](C1=O)Br)SC<br />([C@@H]2C(=O)O)(C)C
|
||||
| CAS Number |
CAS 77442-45-6
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001248) | ||||
| REF 2 | US patent application no. 2004,0023,290, Novel therapeutic agents that modulate enzymatic processes. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.